Valuation: TELCON RF PHARMACEUTICAL. Inc.

Market Cap 10.74B 7.99M 7.17M 6.61M 6M 11.35M 749M 11.67M 79.09M 31.51M 401M 30M 29.36M 1.27B P/E 2024
-2.64x
P/E 2025 -3.84x
Enterprise Value 12.89B 9.59M 8.6M 7.92M 7.2M 13.62M 899M 14M 94.88M 37.8M 482M 35.98M 35.22M 1.52B EV / Sales 2024
3.07x
EV / Sales 2025 1.51x
Free-Float
83.87%
Yield 2024 *
-
Yield 2025 -
07-14 TELCON RF PHARMACEUTICAL. Inc. announced that it has received KRW 4.999999736 billion in funding from Telcon Holdings Co., Ltd. CI
07-06 TELCON RF PHARMACEUTICAL. Inc. announced that it expects to receive KRW 4.999999736 billion in funding from Telcon Holdings Co., Ltd. CI
07-03 KPM TECH Co., Ltd. announced that it expects to receive KRW 22.499999595 billion in funding from TELCON RF PHARMACEUTICAL. Inc. CI
04-18 TELCON RF PHARMACEUTICAL. Inc. announced that it has received KRW 3 billion in funding from Nuon Co., Ltd. CI
04-17 KPM TECH Co., Ltd. announced that it has received KRW 7.9999997 billion in funding from TELCON RF PHARMACEUTICAL. Inc. CI
04-07 TELCON RF PHARMACEUTICAL. Inc. announced that it expects to receive KRW 3 billion in funding from Nuon Co., Ltd. CI
04-07 KPM TECH Co., Ltd. announced that it expects to receive KRW 7.999999854 billion in funding from TELCON RF PHARMACEUTICAL. Inc. CI
23/05/25 Telcon Rf Pharmaceutical To Conduct Capital Increase Of 28 Billion Won RE
22/04/25 TELCON RF PHARMACEUTICAL. Inc. announced that it has received KRW 12 billion in funding from Sangsangin Savings Bank, Sangsangin Plus Savings Bank Co.,Ltd. CI
21/04/25 TELCON RF PHARMACEUTICAL. Inc. announced that it expects to receive KRW 12 billion in funding from Sangsangin Savings Bank, Sangsangin Plus Savings Bank Co.,Ltd. CI
18/03/25 TELCON RF PHARMACEUTICAL. Inc. Auditor Raises 'Going Concern' Doubt CI
23/12/24 ABION Inc. announced that it has received KRW 8.0011152 billion in funding from TELCON RF PHARMACEUTICAL. Inc. CI
12/12/24 TELCON RF PHARMACEUTICAL. Inc. announced that it has received KRW 2.5 billion in funding CI
1 day+1.43%
1 week-4.45%
Current month-4.07%
1 month-15.63%
3 months-18.51%
6 months-67.99%
Current year-79.16%
1 week 1,862
Extreme 1862
2,030
1 month 1,862
Extreme 1862
2,305
Current year 1,700
Extreme 1700
11,500
1 year 1,700
Extreme 1700
11,950
3 years 1,700
Extreme 1700
44,333.33
5 years 1,700
Extreme 1700
108,166.67
10 years 1,700
Extreme 1700
648,333.33
Manager TitleAgeSince
Chief Executive Officer 56 01/11/2017
Director of Finance/CFO 50 28/03/2019
Corporate Officer/Principal 54 30/03/2022
Director TitleAgeSince
Director/Board Member 50 28/03/2019
Director/Board Member 49 28/03/2019
Director/Board Member 56 01/11/2017
Date Insider Type Main position Quantity % Market Cap. Importance
20/8/25 ExerciceCompany 1,111,280 4.8639%
20/8/25 ConversionCompany 1,111,280 4.8639%
30/7/25 FreeCompany 2,222,560 18.4828%
Change 5-day change 1-year change 3-year change Capi.($)
+1.43%-4.45%-81.26%-94.55% 7.87M
-0.51%-4.68%+36.15%+86.63% 388B
-0.62%+8.89%+34.80%+257.80% 235B
+1.43%+2.93%-39.61%+180.21% 127B
-0.11%+7.41%+33.85%+69.56% 87.29B
+4.20%-1.92%-3.88%+549.40% 79.88B
-1.08%+6.34%+42.39%+147.52% 56.23B
-1.78%-13.91%+125.31%+1,344.43% 54.06B
+0.46%-1.33%+9.49%-6.32% 47.6B
+1.17%-2.75%+27.02%+129.50% 46.61B
Average +1.02%-1.27%+18.43%+266.42% 112B
Weighted average by Cap. +0.34%+0.59%+27.39%+226.20%

Financials

2024 2025
Net sales 37.87B 28.17M 25.27M 23.28M 21.15M 40.02M 2.64B 41.14M 279M 111M 1.42B 106M 103M 4.47B 43.16B 32.11M 28.8M 26.54M 24.1M 45.62M 3.01B 46.89M 318M 127M 1.61B 121M 118M 5.1B
Net income -26.32B -19.58M -17.56M -16.18M -14.7M -27.82M -1.84B -28.59M -194M -77.21M -984M -73.49M -71.93M -3.11B -11.46B -8.52M -7.64M -7.04M -6.4M -12.11M -799M -12.45M -84.35M -33.61M -428M -31.99M -31.31M -1.35B
Net Debt 45.65B 33.97M 30.46M 28.07M 25.5M 48.25M 3.18B 49.6M 336M 134M 1.71B 127M 125M 5.39B 2.14B 1.59M 1.43M 1.32M 1.2M 2.27M 150M 2.33M 15.78M 6.29M 80.11M 5.98M 5.86M 253M
Projected Income Statement - Annual - TELCON RF PHARMACEUTICAL. Inc.
Logo TELCON RF PHARMACEUTICAL. Inc.
TELCON RF PHARMACEUTICAL. Inc., formerly TELCON.Inc, is a Korea-based company principally engaged in the manufacture and distribution of connectors and cable assemblies. The Company’s products mainly consist of radio frequency (RF) connectors, RF cables, couplers, dividers, arrestors, terminations, adapters, and other cable assemblies, which are used for wireless communication equipment.
Employees
126
Date Price Change Volume
10/11/26 ₩1,911.00 +1.43% 11,209
09/11/26 ₩1,884.00 -1.00% 7,151
06/11/26 ₩1,903.00 -3.50% 16,059
05/11/26 ₩1,972.00 -0.40% 10,959
04/11/26 ₩1,980.00 -1.00% 7,799
  1. Stock Market
  2. Stocks
  3. A200230 Stock